Radio and PodcastRadio and PodcastLive Radio & Podcasts
Ep. 364 - UCB’s Candid buy, Grand Rounds and leukodystrophies artwork
Science & Medicine

Ep. 364 - UCB’s Candid buy, Grand Rounds and leukodystrophies

BioCentury This Week by BioCentury

May 4, 202632:15Science & Medicine

UCB is the latest biopharma player to consummate a multibillion-dollar deal amid a surge in biotech M&A activity, acquiring Ken Song’s Candid Therapeutics, one of the leading T cell engager companies. On the latest BioCe...

About This Episode

Ep. 364 - UCB’s Candid buy, Grand Rounds and leukodystrophies is an episode from BioCentury This Week by BioCentury. UCB is the latest biopharma player to consummate a multibillion-dollar deal amid a surge in biotech M&A activity, acquiring...

Podcast

This episode belongs to BioCentury This Week.

Listen Online

Use the player on this page to stream the episode online.

Episode Details

Published May 4, 2026, 32:15 long, audio available.

Related Episodes

Continue listening to more episodes from BioCentury This Week.